Sishu Bhawan Hospital & Research Center Profile
Key Indicators
- Authorised Capital ₹ 5.58 Cr
as on 05-12-2024
- Paid Up Capital ₹ 5.58 Cr
as on 05-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -42.82%
(FY 2017)
- Profit -38.71%
(FY 2017)
- Ebitda -38.71%
(FY 2017)
- Net Worth -0.00%
(FY 2017)
- Total Assets -0.03%
(FY 2017)
About Sishu Bhawan Hospital & Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.58 Cr and a paid-up capital of Rs 5.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumit Banerjee and Sayan Chakraborty serve as directors at the Company.
- CIN/LLPIN
U85300WB2012NPL185623
- Company No.
185623
- Company Classification
Private Not For Profit Company
- Incorporation Date
08 Sep 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sishu Bhawan Hospital & Research Center?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Banerjee  | Director | 07-Oct-2020 | Current |
| Sayan Chakraborty | Director | 07-Oct-2020 | Current |
Financial Performance of Sishu Bhawan Hospital & Research Center.
Sishu Bhawan Hospital & Research Center, for the financial year ended 2017, experienced significant reduction in revenue, with a 42.82% decrease. The company also saw a substantial fall in profitability, with a 38.71% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sishu Bhawan Hospital & Research Center?
In 2017, Sishu Bhawan Hospital & Research Center had a promoter holding of 0.09% and a public holding of 99.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pioneer Niketan Private LimitedActive 87 years 11 months
Sumit Banerjee and Sayan Chakraborty are mutual person
- Sanwaraseth Vanijya Private LimitedActive 12 years 2 days
Sumit Banerjee and Sayan Chakraborty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sishu Bhawan Hospital & Research Center?
Unlock and access historical data on people associated with Sishu Bhawan Hospital & Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sishu Bhawan Hospital & Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sishu Bhawan Hospital & Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
